Covered recipient · General Payments record
DOREEN PEREZ MONDELO
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,303.05
- Reported across 74 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $360.59 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $97.52 | 3 |
| GlaxoSmithKline, LLC. | $76.39 | 4 |
| Novo Nordisk AS | $68.73 | 3 |
| Acerta Pharma LLC | $28.86 | 1 |
| Seqirus USA Inc | $28.39 | 1 |
| SHIELD THERAPEUTICS INC | $26.25 | 1 |
| Amgen Inc. | $18.31 | 1 |
| SANOFI PASTEUR INC. | $16.14 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $33.12 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105055384 | CMS |
| ABBVIE INC. | $33.77 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105055386 | CMS |
| ABBVIE INC. | $30.63 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105055388 | CMS |
| Amgen Inc. | $18.31 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117330960 | CMS |
| AstraZeneca Pharmaceuticals LP | $28.86 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104217855 | CMS |
| GlaxoSmithKline, LLC. | $24.60 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116355969 | CMS |
| GlaxoSmithKline, LLC. | $18.69 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116170942 | CMS |
| GlaxoSmithKline, LLC. | $13.66 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116523390 | CMS |
| GlaxoSmithKline, LLC. | $19.44 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116725396 | CMS |
| Novo Nordisk Inc | $17.24 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097146701 | CMS |
| Novo Nordisk Inc | $34.82 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097403018 | CMS |
| Novo Nordisk Inc | $16.67 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097139684 | CMS |
| SANOFI PASTEUR INC. | $16.14 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128743520 | CMS |
| Seqirus USA Inc | $28.39 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125639502 | CMS |
| SHIELD THERAPEUTICS INC | $26.25 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150132979 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.